Printer Friendly

Articles from MondayMorning (September 13, 2010)

1-24 out of 24 article(s)
Title Author Type Words
A popular dietary supplement called "SAMe" may help depressed patients who don't respond to prescription antidepressant treatment, a new study shows. 683
Abbott Laborories Inc. 287
About one in 400 women carry genetic mutations that put them at high risk for breast and ovarian cancer. 245
Astrazeneca Plc. 229
Botox Maker Allergan settles case for $600 million. 367
Bristol-Myers will buy ZymoGenetics for $885 million. Bristol-Myers Squibb Co. 200
California seeks huge fine from UnitedHealth. 319
Cardiome Pharma Corp. 139
Cockroach brains may be a source of new antibiotics capable of killing deadly drug-resistant bacteria, according to research that suggests the germ-spreading pests may be good for something after all. 247
FDA roundup: Merck & Co. 802
Healthcare overhaul won't accelerate spending: report. 452
In a year when news about Alzheimer's disease seems to gyrate between encouraging and disheartening, a new discovery by an 84-year-old scientist has illuminated a new direction. 872
IPO sector. 268
Lilly to invest up to $150 million in venture capital. Eli Lilly & Co. 256
Markets: stocks edged higher Friday, extending a rally that began nearly two weeks ago, as investors hold on to their newfound optimism about the economy. 353
Medical stock spotlight: Skilled Healthcare Group Inc. 466
Onex to buy ResCare in sweetened $390-million deal. ResCare Inc. 322
Otsuka Holdings Inc. 231
Pfizer Inc (New York) agreed to buy closely held FoldRx Pharmaceuticals Inc (Cambridge MA) as it looks to expand into medicines for rare disorders. 291
Sanofi said to offer $71 per share for Genzyme. Sanofi-Aventis SA. 339
Tracking Washington. 426
Vertex Pharmaceuticals Inc's (Cambridge MA) high-profile experimental hepatitis C drug telaprevir cured 65% of patients who had previously failed to be cured by current standard drugs, according to data from a pivotal late-stage clinical trial. 236
Weekly key rates. Brief article 111
Weekly stock performance. Statistical table 454

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters